Based on 3 analysts giving stock ratings to Microbot Medical Inc in the past month.
In the current month, MBOT has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MBOT average Analyst price target in the last month is 5.625.
Based on analysts' estimates, MBOT EPS is projected to reach -0.083 in FY2026Q4, following reported EPS of -0.087 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.09, while Microbot Medical IncMBOT's earnings per share (EPS) for the previous quarter was USD -0.08. EPS for the next quarter is expected at USD -0.08.